Development of a MIRA-CRISPR/Cas12a-based nucleic acid detection system for the discrimination of Panax ginseng and Panax quinquefolium

Yanchao Yang, Dongfan Yang, Meina Shi, Zifeng Huang, Xuening Zhang, Dayuan Zheng, Tien‐Min Gabriel Chu, Wenzhe MaJournal of Ginseng Research 2025 · DOI

TL;DR

Researchers have developed a novel, rapid, and portable nucleic acid detection system using MIRA amplification and CRISPR/Cas12a technology to distinguish between two closely related ginseng species, Panax ginseng (PG) and Panax quinquefolium (PQ). This system offers a promising solution for point-of-care quality control of traditional Chinese medicine (TCM) products, overcoming limitations of traditional methods.

What Problem Does This Paper Address?

Accurately identifying herbal species is crucial for ensuring the efficacy, safety, and authenticity of traditional Chinese medicine (TCM). Panax ginseng (PG) and Panax quinquefolium (PQ) are two widely used ginseng species with similar appearances but distinct pharmacological profiles and market values. This similarity makes them prone to intentional or unintentional substitution, especially in processed forms like powders or extracts, which renders traditional morphological and microscopic identification methods inadequate. While advanced chemical profiling techniques exist, they often require specialized equipment and expertise. Existing molecular methods like DNA barcoding, while effective for pure materials, can struggle with complex mixtures found in many TCM products. Therefore, there's a need for a rapid, sensitive, specific, and portable method for on-site species discrimination that can handle complex herbal samples.

Methods

The core of this work is the integration of two key technologies:

  • Multienzyme Isothermal Rapid Amplification (MIRA): This technique allows for rapid amplification of target DNA sequences at a constant temperature, eliminating the need for thermal cyclers and making it suitable for field applications. The researchers optimized MIRA primer sets and reaction temperatures to achieve efficient amplification.
  • CRISPR/Cas12a System: This revolutionary gene-editing technology has been repurposed for nucleic acid detection. In this system, a guide RNA (crRNA) directs the Cas12a enzyme to a specific DNA target. Upon binding, Cas12a becomes activated and exhibits "collateral cleavage" activity, meaning it non-specifically cleaves a nearby reporter molecule (in this case, a single-stranded DNA probe). This cleavage generates a detectable signal.

The researchers designed species-specific crRNAs targeting highly divergent mitochondrial gene regions (specifically, the nad4 intron 2) of PG and PQ, as nuclear ribosomal DNA (ITS2) showed too much similarity. They then combined MIRA amplification with CRISPR/Cas12a detection, offering two readout options:

  • Fluorescence Detection: Cleavage of a fluorescently labeled ssDNA reporter releases fluorescence, which is measured using a microplate reader.
  • Lateral Flow Assay (LFA): Cleavage of an LFA-compatible ssDNA reporter, which is conjugated to gold nanoparticles, results in visible bands on a test strip, similar to a pregnancy test.

The system was optimized for Cas12a/crRNA ribonucleoprotein (RNP) concentration and ssDNA reporter concentration.

Datasets

The study utilized standard medicinal materials of Panax ginseng (PG) and Panax quinquefolium (PQ) obtained from the National Institutes for Food and Drug Control. Additionally, 29 commercial Panax samples were collected from pharmacies and online platforms for real-world testing and validation. DNA barcoding was used as a comparative method for validation.

Key Insights and Ideas

  • Mitochondrial Genes for Discrimination: Recognizing the high similarity in nuclear DNA regions like ITS2 between PG and PQ, the researchers strategically targeted mitochondrial genes, which often exhibit greater divergence and are thus better suited for designing species-specific molecular probes.
  • CRISPR's Collateral Cleavage for Sensitivity: The "collateral cleavage" activity of Cas12a is a game-changer. It amplifies the detection signal by cleaving many reporter molecules for each target molecule bound, leading to significantly enhanced sensitivity compared to methods relying solely on target binding.
  • Dual Readout for Versatility: Offering both fluorescence and LFA readouts provides flexibility. Fluorescence offers higher sensitivity for laboratory settings, while LFA provides a rapid, instrument-free option for point-of-care testing in the field.
  • Handling Complex Mixtures: The system's ability to detect specific components within multi-herbal patent medicines, where traditional DNA barcoding struggles due to overlapping PCR products, is a significant advantage for TCM quality control.

Key Results

  • High Sensitivity: The MIRA-CRISPR/Cas12a system achieved a detection limit of 10⁻⁴ ng/µL for fluorescence detection and 10⁻³ ng/µL for LFA detection, representing a substantial improvement over MIRA alone.
  • High Specificity: Species-specific crRNAs demonstrated excellent discrimination between PG and PQ, with no cross-reactivity observed.
  • Practical Applicability: The system successfully identified PG and PQ in 29 commercial samples, including medicinal materials, herbal pieces, and patent medicines. It correctly identified mislabeled samples and samples containing mixtures of both species.
  • ROC-AUC Analysis: Receiver Operating Characteristic (ROC) curve analysis confirmed the excellent discriminatory performance of the system for both fluorescence and LFA readouts, with AUC values exceeding 0.91.

Limitations and Future Work

  • Workflow Simplification: The current workflow involves two steps (MIRA amplification and CRISPR/Cas12a detection). Future work aims to develop a "one-pot" reaction to further streamline the process.
  • Broader Species Coverage: The current study focused on PG and PQ. Future research will aim to expand the system to distinguish other Panax species and potentially other herbal medicines, which may require sequencing additional targets or exploring alternative genes due to limitations in public database information.
  • LFA Sensitivity Enhancement: While LFA is portable and instrument-free, its sensitivity is inherently lower than fluorescence detection. Future improvements may focus on sample concentration, volume optimization, and advanced band intensity quantification tools.
  • crRNA Design Optimization: Further investigation into target sequence characteristics and the development of crRNA design algorithms specifically for CRISPR-based nucleic acid detection platforms are anticipated to enhance performance.

Summary updated

Abstract

This method offers a promising solution for point-of-care testing (POCT) in TCM quality control and provides a foundation for broader applications of CRISPR-based molecular authentication in herbal medicine.
BibTeX
@article{yang2025development,
  author = {Yanchao Yang and Dongfan Yang and Meina Shi and Zifeng Huang and Xuening Zhang and Dayuan Zheng and Tien‐Min Gabriel Chu and Wenzhe Ma},
  title = {{Development of a MIRA-CRISPR/Cas12a-based nucleic acid detection system for the discrimination of Panax ginseng and Panax quinquefolium}},
  journal = {Journal of Ginseng Research},
  year = {2025},
  doi = {10.1016/j.jgr.2025.11.011},
}
Figure